187 related articles for article (PubMed ID: 32523707)
1. Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.
Papastergiou J; Donnelly M; Li W; Sindelar RD; van den Bemt B
Can J Kidney Health Dis; 2020; 7():2054358120922617. PubMed ID: 32523707
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.
Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; El-Dahiyat F
Sci Rep; 2024 Mar; 14(1):7284. PubMed ID: 38538618
[TBL] [Abstract][Full Text] [Related]
3. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
[TBL] [Abstract][Full Text] [Related]
4. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program.
Komenda P; Lavallee B; Ferguson TW; Tangri N; Chartrand C; McLeod L; Gordon A; Dart A; Rigatto C
Am J Kidney Dis; 2016 Oct; 68(4):582-590. PubMed ID: 27257016
[TBL] [Abstract][Full Text] [Related]
6. "Positive Kidney Health": Implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease.
Vu A; Nicholas SB; Waterman AD; Madievsky R; Cheng F; Chon J; Fu JY; Mangione CM; Norris KC; Duru OK
J Am Pharm Assoc (2003); 2023; 63(2):681-689. PubMed ID: 36593152
[TBL] [Abstract][Full Text] [Related]
7. Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.
Tesfaye W; Krass I; Sud K; Johnson DW; Van C; Versace VL; McMorrow R; Fethney J; Mullan J; Tran A; Robson B; Vagholkar S; Kairaitis L; Gisev N; Fathima M; Tong V; Coric N; Castelino RL
BMJ Open; 2023 Dec; 13(12):e079110. PubMed ID: 38128937
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a chronic kidney disease risk assessment service in community pharmacies.
Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
Nephrology (Carlton); 2019 Mar; 24(3):301-307. PubMed ID: 29493051
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study.
Hirst JA; Hill N; O'Callaghan CA; Lasserson D; McManus RJ; Ogburn E; Mena JMO; Shine B; Taylor CJ; Vazquez-Montes MD; Yang Y; Hobbs FR
Br J Gen Pract; 2020 Apr; 70(693):e285-e293. PubMed ID: 32041766
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).
Stevens LA; Li S; Kurella Tamura M; Chen SC; Vassalotti JA; Norris KC; Whaley-Connell AT; Bakris GL; McCullough PA
Am J Kidney Dis; 2011 Mar; 57(3 Suppl 2):S9-16. PubMed ID: 21338849
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled R
Al Hamarneh YN; Tsuyuki RT; Jones CA; Manns B; Tonelli M; Scott-Douglass N; Jindal K; Tink W; Hemmelgarn BR
Am J Kidney Dis; 2018 Jan; 71(1):42-51. PubMed ID: 28912054
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacist intervention in patients with renal impairment.
Pourrat X; Sipert AS; Gatault P; Sautenet B; Hay N; Guinard F; Guegan F; Halimi JM
Int J Clin Pharm; 2015 Dec; 37(6):1172-9. PubMed ID: 26385098
[TBL] [Abstract][Full Text] [Related]
13. Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care.
Hirst JA; Montes MDV; Taylor CJ; Ordóñez-Mena JM; Ogburn E; Sharma V; Shine B; James T; Hobbs FR
Br J Gen Pract; 2018 Aug; 68(673):e524-e530. PubMed ID: 29970394
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons.
Cepoi V; Onofriescu M; Segall L; Covic A
Int Urol Nephrol; 2012 Feb; 44(1):213-20. PubMed ID: 21360160
[TBL] [Abstract][Full Text] [Related]
15. Glomerular filtration rate measured by (99m) Tc-DTPA renal dynamic imaging is significantly lower than that estimated by the CKD-EPI equation in horseshoe kidney patients.
Qi Y; Hu P; Xie Y; Wei K; Jin M; Ma G; Li Q; Xu B; Chen X
Nephrology (Carlton); 2016 Jun; 21(6):499-505. PubMed ID: 26517584
[TBL] [Abstract][Full Text] [Related]
16. [Community pharmacists' interventions to prevent and screen chronic kidney disease patients].
Belaiche S; Mercier E; Cuny D; Kambia N; Wierre P; Bertoux É; Mascaut D; Azar R; Bataille P; Bourdon F; Mac Namara É; Maisonneuve N; Painchart B; Vrigneau L; Noël C; Décaudin B; Glowacki F;
Nephrol Ther; 2017 Apr; 13(2):87-92. PubMed ID: 27810277
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.
Escribá-Martí G; Cámara-Ramos I; Climent-Catalá MT; Escudero-Quesada V; Salar-Ibáñez L
PLoS One; 2022; 17(12):e0278648. PubMed ID: 36548299
[TBL] [Abstract][Full Text] [Related]
18. Routine reporting of estimated glomerular filtration rate (eGFR) in African laboratories and the need for its increased utilisation in clinical practice.
Adebisi SA
Niger Postgrad Med J; 2013 Mar; 20(1):57-62. PubMed ID: 23661212
[TBL] [Abstract][Full Text] [Related]
19. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
Skali H; Uno H; Levey AS; Inker LA; Pfeffer MA; Solomon SD
Am Heart J; 2011 Sep; 162(3):548-54. PubMed ID: 21884875
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
